ResearcherSeoul National UniversityNo recent work listed
Yong Bum Yoon
Matched on ORCID iD 0000-0002-4217-7619; OpenAlex author ID A5090723576. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 20
2011: 1 paper · 2012: 4 papers · 2013: 1 paper
Papers 6
- Clinical significance and revisiting the meaning of CA 19-9 blood level before and after the treatment of pancreatic ductal adenocarcinoma: analysis of 1,446 p… Last author DOI 10.1371/journal.pone.0078977↗
- Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for… Last author DOI 10.1007/s00280-012-1918-7↗
- The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. Last author DOI 10.1097/mpa.0b013e318221c903↗
- Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. Last author DOI 10.1097/mpa.0b013e318249d62e↗
- Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue microarrays. Co-author DOI 10.1245/s10434-012-2277-7↗
- Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property of gemcitabine in pancreatic cancer. Last author DOI 10.1097/mpa.0b013e3182156d5a↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ji Kon Ryu · 5 shared papers, 2011–2013 · strength 0.16
- Paper Clinical significance and revisiting the meaning of CA 19-9 blood level before and after the treatment of pancreatic du… DOI 10.1371/journal.pone.0078977↗
- Paper The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. DOI 10.1097/mpa.0b013e318221c903↗
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Yong‐Tae Kim · 4 shared papers, 2012–2013 · strength 0.13
- Paper Clinical significance and revisiting the meaning of CA 19-9 blood level before and after the treatment of pancreatic du… DOI 10.1371/journal.pone.0078977↗
- Paper The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. DOI 10.1097/mpa.0b013e318221c903↗
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Joo Kyung Park · 4 shared papers, 2011–2013 · strength 0.12
- Paper Clinical significance and revisiting the meaning of CA 19-9 blood level before and after the treatment of pancreatic du… DOI 10.1371/journal.pone.0078977↗
- Paper The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. DOI 10.1097/mpa.0b013e318221c903↗
- Paper Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue … DOI 10.1245/s10434-012-2277-7↗
- Jin‐Hyeok Hwang · 3 shared papers, 2012 · strength 0.09
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Paper Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent… DOI 10.1007/s00280-012-1918-7↗
- Paper Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue … DOI 10.1245/s10434-012-2277-7↗
- Sang Hyub Lee · 3 shared papers, 2011–2012 · strength 0.09
- Paper The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. DOI 10.1097/mpa.0b013e318221c903↗
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Paper Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property … DOI 10.1097/mpa.0b013e3182156d5a↗
- Jun Kyu Lee · 2 shared papers, 2011–2012 · strength 0.06
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Paper Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property … DOI 10.1097/mpa.0b013e3182156d5a↗
- Won Jae Yoon · 2 shared papers, 2011–2012 · strength 0.06
- Paper The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. DOI 10.1097/mpa.0b013e318221c903↗
- Paper Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property … DOI 10.1097/mpa.0b013e3182156d5a↗
- Woo Hyun Paik · 1 shared paper, 2013 · strength 0.04
- Jaihwan Kim · 1 shared paper, 2013 · strength 0.04
- Dong‐Won Ahn · 1 shared paper, 2012 · strength 0.03
- Kim Js · 1 shared paper, 2012 · strength 0.03
- Sung Whan Ha · 1 shared paper, 2012 · strength 0.03
- Ho‐Seong Han · 1 shared paper, 2012 · strength 0.03
- Haeryoung Kim · 1 shared paper, 2012 · strength 0.03
- Seock‐Ah Im · 1 shared paper, 2012 · strength 0.03
- Eui Kyu Chie · 1 shared paper, 2012 · strength 0.03
- Sun‐Whe Kim · 1 shared paper, 2012 · strength 0.03
- Yung‐Jue Bang · 1 shared paper, 2012 · strength 0.03
- Yong‐Tae Kim · 1 shared paper, 2011 · strength 0.03
- Sang Myung Woo · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.